Harmane: An atypical neurotransmitter?

[1]  T. Herraiz,et al.  Naturally-occurring tetrahydro-β-carboline alkaloids derived from tryptophan are oxidized to bioactive β-carboline alkaloids by heme peroxidases. , 2014, Biochemical and biophysical research communications.

[2]  M. M. Aglawe,et al.  Participation of central imidazoline binding sites in antinociceptive effect of ethanol and nicotine in rats , 2014, Fundamental & clinical pharmacology.

[3]  M. Zarrindast,et al.  Suggesting a possible role of CA1 histaminergic system in harmane-induced amnesia , 2013, Neuroscience Letters.

[4]  D. Finn,et al.  Behavioural, neurochemical and neuroendocrine effects of the endogenous β-carboline harmane in fear-conditioned rats , 2013, Journal of psychopharmacology.

[5]  P. Faure,et al.  Electrophysiological characterization of harmane-induced activation of mesolimbic dopamine neurons. , 2010, European journal of pharmacology.

[6]  M. Airaksinen,et al.  Tetrahydro-β-carbolines and Corresponding Tryptamines: In Vitro Inhibition of Serotonin, Dopamine and Noradrenaline Uptake in Rat Brain Synaptosomes , 2009 .

[7]  V. Arán,et al.  Oxidative metabolism of the bioactive and naturally occurring beta-carboline alkaloids, norharman and harman, by human cytochrome P450 enzymes. , 2008, Chemical research in toxicology.

[8]  D. Deutsch,et al.  Anandamide transport: a critical review. , 2005, Life sciences.

[9]  E. Robinson,et al.  Harmane and harmalan are bioactive components of classical clonidine-displacing substance. , 2004, Biochemistry.

[10]  N. Morgan,et al.  Effects of the beta-carbolines, harmane and pinoline, on insulin secretion from isolated human islets of Langerhans. , 2003, European journal of pharmacology.

[11]  A. Hudson,et al.  Endogenous β‐Carbolines as Clonidine‐Displacing Substances , 2003, Annals of the New York Academy of Sciences.

[12]  N. Morgan,et al.  Comparative Effects of Efaroxan and b‐Carbolines on the Secretory Activity of Rodent and Human b Cells , 2003, Annals of the New York Academy of Sciences.

[13]  A. Siafaka-Kapadai,et al.  Uptake and metabolism of [3H]anandamide by rabbit platelets , 2003 .

[14]  D. Nutt,et al.  Behavioral, neuroendocrine and neurochemical effects of the imidazoline I2 receptor selective ligand BU224 in naive rats and rats exposed to the stress of the forced swim test , 2003, Psychopharmacology.

[15]  G. Head,et al.  Importance of imidazoline-preferring receptors in the cardiovascular actions of chronically administered moxonidine, rilmenidine and clonidine in conscious rabbits , 2003, Journal of hypertension.

[16]  A. Siafaka-Kapadai,et al.  Uptake and metabolism of [3H]anandamide by rabbit platelets. Lack of transporter? , 2003, European journal of biochemistry.

[17]  S. Handley,et al.  Characterization of the discriminable stimulus produced by 2‐BFI: effects of imidazoline I2‐site ligands, MAOIs, β‐carbolines, agmatine and ibogaine , 2002, British journal of pharmacology.

[18]  D. Nutt,et al.  β-carboline binding to imidazoline receptors , 2001 .

[19]  H. Prast,et al.  Nitric oxide as modulator of neuronal function , 2001, Progress in Neurobiology.

[20]  D. Nutt,et al.  beta-carboline binding to imidazoline receptors. , 2001, Drug and alcohol dependence.

[21]  R. Glennon,et al.  Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors , 2000 .

[22]  C. Polidori,et al.  Hyperphagic effect of novel compounds with high affinity for imidazoline I(2) binding sites. , 2000, European journal of pharmacology.

[23]  R. Blakely,et al.  Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells. , 2000, The Journal of pharmacology and experimental therapeutics.

[24]  I. Musgrave,et al.  Harmane produces hypotension following microinjection into the RVLM: possible role of I1‐imidazoline receptors , 2000, British journal of pharmacology.

[25]  R. Glennon,et al.  Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors. , 2000, Drug and alcohol dependence.

[26]  Eiji Takeda,et al.  Identification and Functional Characterization of a Na+-independent Neutral Amino Acid Transporter with Broad Substrate Selectivity* , 1999, The Journal of Biological Chemistry.

[27]  D. Reis,et al.  Uptake of Agmatine into Rat Brain Synaptosomes: Possible Role of Cation Channels , 1997, Journal of neurochemistry.

[28]  M. Airaksinen,et al.  Binding of pinoline on the 5-hydroxytryptamine transporter: competitive interaction with [3H] citalopram. , 1997, Pharmacology & toxicology.

[29]  D. Reis,et al.  Imidazoline receptors and their endogenous ligands. , 1996, Annual review of pharmacology and toxicology.

[30]  D. Reis,et al.  Agmatine Is Widely and Unequally Distributed in Rat Organs , 1995, Annals of the New York Academy of Sciences.

[31]  D. Reis,et al.  Agmatine: an endogenous clonidine-displacing substance in the brain. , 1994, Science.

[32]  H. Rommelspacher,et al.  [3H]Harman Binding Experiments. II: Regional and Subcellular Distribution of Specific [3H]Harman Binding and Monoamine Oxidase Subtypes A and B Activity in Marmoset and Rat , 1991, Journal of neurochemistry.

[33]  Y. Burstein,et al.  Isolation and partial purification of a clonidine-displacing endogenous brain substance. , 1984, European journal of biochemistry.

[34]  M. Airaksinen,et al.  beta-Carbolines, psychoactive compounds in the mammalian body. Part II: Effects. , 1981, Medical biology.

[35]  M. Airaksinen,et al.  Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin and dopamine uptake by human blood platelets. , 2009, Acta pharmacologica et toxicologica.

[36]  M. Airaksinen,et al.  Affinity of beta-carbolines on rat brain benzodiazepine and opiate binding sites. , 1980, Medical biology.

[37]  M. Airaksinen,et al.  Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin, dopamine and noradrenaline uptake in rat brain synaptosomes. , 1980, Acta Pharmacologica et Toxicologica.

[38]  H. Rommelspacher,et al.  Tetrahydronorharmane modulates the depolarisation-induced efflux of 5-hydroxytryptamine and dopamine and is released by high potassium concentration from rat brain slices. , 1979, European journal of pharmacology.

[39]  M. Airaksinen,et al.  The uptake of 6-methoxy-1,2,3,4-tetrahydro-beta-carboline and its effect on 5-hydroxytryptamine uptake and release in blood platelets. , 2009, Acta pharmacologica et toxicologica.

[40]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[41]  B. Ho,et al.  6‐Methoxy‐1,2,3,4‐tetrahydro‐β‐carboline–α serotonin elevator 1 , 1972, Journal of neurochemistry.